Enjoy complimentary customisation on priority with our Enterprise License!
The endovascular abdominal aortic aneurysm (AAA) repair devices market size is forecast to increase by USD 724.4 billion at a CAGR of 5.12% between 2023 and 2028. The market is experiencing significant growth due to the increasing prevalence of AAAs and the aging population. Imaging techniques, such as CT scans and ultrasounds, enable early detection of AAAs, leading to increased elective procedures. Custom-made and off-the-shelf fenestrated and branched stent grafts are gaining popularity for their effectiveness in treating complex AAAs. However, high treatment costs and healthcare expenditure are major challenges for market expansion. Healthcare facilities and patients seek cost-effective solutions to reduce the financial burden of these procedures. The use of advanced materials in stent grafts is a potential solution to address the high costs while maintaining the durability and effectiveness of the devices.
The aging population in the United States continues to face a significant health challenge with the increasing prevalence of unhealthy lifestyles and obesity rates. One of the most critical health concerns for this demographic is the rising incidence of aortic aneurysms, which can lead to life-threatening complications if left untreated. Traditional open surgery has long been the go-to treatment for aortic aneurysms. However, the medical devices industry has seen a shift towards minimally invasive endovascular procedures for the repair of these conditions.
Endovascular technology, including stent-grafts and aortic endografts, has emerged as a promising alternative to open surgery for treating aortic aneurysms. These devices are designed to be inserted through a catheter, guided by imaging techniques, and positioned within the aorta to reinforce the weakened aortic wall. The use of these devices has gained traction due to their minimally invasive nature, reduced recovery time, and lower risk of complications compared to open surgery. The healthcare expenditure on aortic aneurysm repair devices is expected to expand significantly in the coming years as the demand for advanced treatment options grows. The market for these devices is driven by the increasing prevalence of aortic aneurysms in the geriatric population, the rising awareness of minimally invasive procedures, and the cost-effectiveness of endovascular treatments compared to open surgery.
The vascular system, which includes the aorta and its branches, is a complex network of blood vessels that plays a crucial role in the body's circulatory system. Aneurysms, which are localized dilations of the aortic wall, can lead to life-threatening complications such as rupture, which can result in fatal bleeding. Endovascular repair devices, such as stent grafts and aortic endografts, offer a minimally invasive solution to address these conditions. The use of these devices involves the insertion of a catheter, guided by imaging techniques, through a small incision in the groin or the wrist. A guidewire is then threaded through the catheter to the site of the aneurysm.
The stent graft or aortic endograft is then deployed, expanding to seal off the aneurysm and reinforce the weakened aortic wall. The advantages of endovascular repair devices are numerous. They offer a less invasive approach to treating aortic aneurysms, reducing the risk of complications and shortening the recovery time compared to open surgery. Additionally, the cost-effectiveness of endovascular procedures is a significant factor driving the growth of the market for these devices. In conclusion, the growing need for advanced treatment options for aortic aneurysms in the geriatric population is driving the expansion of the market for endovascular repair devices in the United States.
These devices offer a minimally invasive solution to address the complex vascular conditions, reducing the risk of complications and shortening the recovery time compared to traditional open surgery. The use of imaging techniques, catheters, and guidewires enables the precise placement of these devices, making them an attractive alternative to open surgery for treating aortic aneurysms. The cost-effectiveness of endovascular procedures is also a significant factor driving the growth of the market for these devices. Healthcare facilities are increasingly adopting endovascular technology to provide their patients with the best possible care while reducing healthcare expenditure.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The hospital segment is estimated to witness significant growth during the forecast period. The endovascular AAA repair devices market is primarily driven by hospitals as the primary end-users in the United States. The increasing prevalence of abdominal aortic aneurysms (AAAs) among the geriatric population and the unhealthy lifestyle choices leading to obesity rates are significant factors fueling the demand for advanced treatment options. Endovascular repair techniques, including stent-grafts and aortic endografts, offer numerous advantages over traditional open surgeries. These advantages include shorter recovery times, reduced complications, and less invasive procedures. Hospitals are well-equipped to perform these complex treatments due to their advanced healthcare infrastructure and skilled medical staff. The growing awareness among patients and healthcare professionals regarding the benefits of endovascular AAA repair further bolsters the acceptance of these devices in hospitals.
Get a glance at the market share of various segments Request Free Sample
The Hospital segment accounted for USD 1865.70 million in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 46% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
In North America, the market for endovascular repair devices for Aortic Abdominal Aneurysms (AAAs) witnessed significant expansion in 2023. With an aging population and the prevalence of aortic aneurysms increasing, there is a growing demand for advanced endovascular AAA repair devices. Key players in the industry, such as Medtronic, Cook Group, and Endologix, are investing heavily in research and development, as well as marketing, to offer innovative solutions. To promote the adoption of endovascular AAA repair techniques, there is a heightened emphasis on clinical guidelines and reimbursement policies. As patients and healthcare providers prefer less invasive treatments and awareness of aortic health grows, the North American market for these devices is anticipated to continue expanding throughout the forecast period.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Aging population and rising prevalence of abdominal aortic aneurysms is the key driver of the market. The global market for endovascular Abdominal Aortic Aneurysm (AAA) repair devices is experiencing growth due to the rising prevalence of abdominal aortic aneurysms and the increasing number of elderly individuals. Aging is a significant risk factor for the development of AAA, as degenerative changes in blood vessels increase with age. Consequently, the demand for less invasive treatment options, such as endovascular repair devices, is on the rise. In the United States, the aging baby boomer population is contributing to the increase in AAA cases. As a result, there is a growing need for effective and minimally invasive treatment alternatives. Reimbursement coverage for endovascular AAA repair procedures in ambulatory surgical centers and specialty clinics is also driving market growth.
Alternative therapies to open surgical repair, such as endovascular repair, offer advantages like reduced hospital stays, quicker recovery times, and lower healthcare spending. The endovascular AAA repair devices market is expected to continue expanding in the coming years as the population ages and the demand for less invasive treatment options increases.
Shift towards custom-made and off-the-shelf fenestrated and branched endografts is the upcoming trend in the market. The global market for endovascular abdominal aortic aneurysm (AAA) repair devices is witnessing significant growth due to the increasing prevalence of chronic diseases such as diabetes and the need for early diagnosis and treatment. Custom-made and off-the-shelf fenestrated and branching endografts are gaining popularity in the market to address the complexities of treating aneurysms. These endografts are designed to fit precisely to each patient's unique anatomy, ensuring optimal results in challenging situations where traditional implants may not be suitable. Pre-fabricated fenestrated and branching endografts offer a more accessible and cost-effective alternative for specific anatomical configurations, reducing procedure time and expenses.
Notable examples of these products include Medtronic's Endurant II/IIs stent graft system and Cook Group's Zenith Fenestrated Endovascular Graft, which incorporate fenestrations and branches to treat complex aortic aneurysms with improved patient outcomes and reduced procedural complexity. Hospitals and healthcare infrastructure continue to invest in point-of-care testing and advanced imaging technologies to ensure accurate diagnosis and timely intervention, further fueling the demand for advanced AAA repair devices.
High costs associated with endovascular procedures and devices is a key challenge affecting the market growth. The market experiences significant challenges due to the elevated costs associated with these advanced treatments and the necessary equipment. The high expense is attributed to the sophisticated technology, specialized instruments, and skilled medical personnel required for successful implementation. Consequently, access to advanced endovascular therapies for AAA repairs may be limited in economically disadvantaged regions, such as India and Brazil, due to insufficient healthcare resources, infrastructure, and endovascular devices. This disparity in healthcare access may lead to compromised patient outcomes if individuals opt for less effective, cheaper alternatives or experience delayed treatments. The high treatment costs remain a significant barrier to market expansion in these regions, despite the potential benefits of these innovative therapies for improving patient care and outcomes.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories - Our company provides innovative endovascular solutions for the repair of Abdominal Aortic Aneurysms (AAAs), including the Prostar XL and Perclose ProGlide devices. These advanced technologies enable minimally invasive procedures, reducing the need for open surgery and promoting faster patient recovery. Endovascular repair devices offer a more efficient and effective alternative to traditional surgical methods. The Prostar XL system ensures precise aneurysm sealing, while the Perclose ProGlide system simplifies the vascular closure process. Our commitment to medical advancement and patient care drives US to continually improve these devices and expand our product offerings.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Endovascular technology has revolutionized the treatment landscape for aortic aneurysms, particularly abdominal aortic aneurysms (AAAs), in recent years. The geriatric population, with its higher prevalence of unhealthy lifestyle factors such as obesity rates, smoking, and high blood pressure, is a significant target demographic for these advanced treatment options. AAA repair devices, including stent-grafts and aortic endografts, offer minimally invasive procedures with improved patient outcomes, shorter hospital stays, and faster recovery times compared to open surgery. The effectiveness of these devices in preventing aneurysm rupture, a life-threatening condition, has been well-documented. However, there are risks and benefits associated with these procedures, including complications such as graft infection, graft migration, and reinterventions.
Innovative devices continue to emerge, utilizing synthetic fabric grafts and polymers or metal materials to enhance durability and flexibility. Imaging techniques, such as ultrasound screening, play a crucial role in early diagnosis and treatment awareness. Health statistics indicate that healthcare expenditure on medical devices for endovascular repair procedures, including stent grafts, catheters, guidewires, and imaging equipment, will continue to increase as the demand for minimally invasive treatments grows. Chronic diseases like atherosclerosis and diabetes, which contribute to the development of aneurysms, necessitate healthcare infrastructure improvements, including specialized clinics and ambulatory surgical centers. Healthcare reforms, awareness campaigns, and screening programs aim to increase access to skilled interventionalists and reimbursement coverage for these procedures.
The market expansion for endovascular repair devices is driven by the rising prevalence of aneurysms, healthcare spending, and the growing number of elective procedures. The aorta, a vital component of the vascular system, requires continuous attention and research to develop more effective and cost-efficient treatment options.
Market Scope |
|
Report Coverage |
Details |
Page number |
164 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.12% |
Market growth 2024-2028 |
USD 724.4 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.78 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 46% |
Key countries |
US, Germany, Japan, China, and UK |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, Artivion Inc., Braile Biomedica, Cardinal Health Inc., Cook Group Inc., Edwards Lifesciences Corp., Endologix LLC, Koninklijke Philips N.V., LeMaitre Vascular Inc., Lifetech Scientific Corp, Lombard Medical Ltd., Medtronic, MicroPort Scientific Corp., Terumo Corp., and W. L. Gore and Associates Inc. |
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.